This is a U.S. news story, published by CNBC, that relates primarily to Optum Rx news.
For more U.S. news, you can click here:
more U.S. newsFor more Optum Rx news, you can click here:
more Optum Rx newsFor more health policy news, you can click here:
more health policy newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
role insulin manufacturers. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest health insurers news, drug manufacturers news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
insulin manufacturers Eli LillyCNBC
•74% Informative
Federal Trade Commission sues U.S. health companies that negotiate insulin prices.
The FTC argues the drug middlemen boost profits while "artificially" inflating costs for patients.
The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx , CVS Health's Caremark and Cigna 's Express Scripts .
All are owned by or connected to health insurers and collectively administer about 80% of the nation's prescriptions.
VR Score
83
Informative language
88
Neutral language
31
Article tone
formal
Language
English
Language complexity
63
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links